Zevra Therapeutics (ZVRA) Metrics: History & Chart

Zevra Therapeutics, Inc.(ZVRA)

Biotechnology · Boston, MA

$10.73+0.03 (+0.28%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc., founded in 2006 and based in Celebration, Florida, is a biopharmaceutical company dedicated to discovering and developing innovative treatments for rare diseases. The company employs its proprietary Ligand Activated Therapy (LAT) technology to create novel prodrug versions of existing FDA-approved medications or to enable new applications for other compounds, primarily addressing serious medical conditions within the United States. Zevra's development pipeline is strategically concentrated on high-unmet-need therapeutic areas, including attention deficit hyperactivity disorder (ADHD), stimulant use disorder, and various rare central nervous system (CNS) conditions, such as idiopathic hypersomnia (IH). Their lead product candidate, KP1077, which is a prodrug of d-methylphenidate (known as serdexmethylphenidate), is currently in Phase II clinical trials for the treatment of both IH and narcolepsy. Another key prodrug candidate, KP879, is also advancing through Phase II studies for stimulant use disorder. In addition to its pipeline, Zevra has successfully secured FDA approval for two products: AZSTARYS, a once-daily treatment for ADHD in patients aged six years and older, and APADAZ, an immediate-release combination product containing benzhydrocodone (a prodrug of hydrocodone) and acetaminophen. The company's product portfolio also includes arimoclomol, and it holds collaboration and licensing agreements with KVK-Tech, Inc. and Commave Therapeutics SA. Formerly known as KemPharm, Inc., the company officially rebranded to Zevra Therapeutics, Inc. in February 2023.

Boston, MA

61 employees

zevra.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Neil F. McFarlane

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-5.31%
30D Total Return	-13.71%
YTD Total Return	+19.42%
1Y Total Return	+9.74%
3Y Total Return	+133.14%
5Y Total Return	+20.21%
10Y Total Return	-85.10%
15Y Total Return	N/A
20Y Total Return	N/A

2026	+19.42%
2025	+7.43%
2024	+27.33%
2023	+42.70%
2022	-47.30%
2021	-22.23%
2020

CAGR TTM	+9.69%
CAGR 3Y	+32.59%
CAGR 5Y	+3.75%
CAGR 10Y	-17.34%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	11.50
PE Ratio Avg TTM	10.12
PE Ratio Avg 3Y	10.12
Current VS TTM Avg	+13.65%
Current VS 3Y Avg	+13.65%
Current VS 5Y Avg	+13.65%

All Metrics

ZVRA Valuation Metrics

ZVRA Stock Price Metrics

ZVRA Dividend Metrics

ZVRA Growth Rate Metrics

ZVRA Discounted Cash Flow Metrics

ZVRA Returns By Period

ZVRA Yearly Returns

ZVRA Average Annual Returns By Period (CAGR)

ZVRA Revenue Metrics

ZVRA PE Ratio Metrics

ZVRA PS Ratio Metrics

ZVRA PB Ratio Metrics

ZVRA Price to Free Cash Flow Ratio Metrics

ZVRA Debt to Equity Ratio Metrics

ZVRA PEG Ratio Metrics

ZVRA FCF Yield

ZVRA Earnings Yield

ZVRA EBITDA Yield

ZVRA OCF Yield

ZVRA EV/EBIT Ratio Metrics

ZVRA EV/EBITDA Ratio Metrics

ZVRA EV/Assets Ratio Metrics

ZVRA EV/Sales Ratio Metrics

ZVRA Current Ratio Metrics

ZVRA Quick Ratio Metrics

ZVRA ROIC Metrics

ZVRA Return on Assets Metrics

ZVRA Return on Equity Metrics

ZVRA Net Profit Margin Metrics

ZVRA Gross Profit Margin Metrics

ZVRA Tax Rate Metrics

PS Ratio	4.82
PS Ratio Avg TTM	5.63
PS Ratio Avg 3Y	10.10
Current VS TTM Avg	-14.32%
Current VS 3Y Avg	-52.25%
Current VS 5Y Avg	-58.21%

PB Ratio	3.02
PB Ratio Avg TTM	3.55
PB Ratio Avg 3Y	4.41
Current VS TTM Avg	-14.93%
Current VS 3Y Avg	-31.56%
Current VS 5Y Avg	-1.01%

PFCF Ratio	20.16
PFCF Ratio Avg TTM	44.71
PFCF Ratio Avg 3Y	44.71
Current VS TTM Avg	-54.91%
Current VS 3Y Avg	-54.91%
Current VS 5Y Avg	-22.39%

Debt/Equity Ratio	0.01
Debt/Equity Ratio Avg TTM	0.28
Debt/Equity Ratio Avg 3Y	0.65
Current VS TTM Avg	-97.59%
Current VS 3Y Avg	-98.94%
Current VS 5Y Avg	-98.40%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	4.96%
FCF Yield Avg TTM	2.85%
FCF Yield Avg 3Y	2.85%
Current VS TTM Avg	+73.78%
Current VS 3Y Avg	+73.78%
Current VS 5Y Avg	+23.51%

Earnings Yield	8.69%
Earnings Yield Avg TTM	11.77%
Earnings Yield Avg 3Y	11.77%
Current VS TTM Avg	-26.20%
Current VS 3Y Avg	-26.20%
Current VS 5Y Avg	-7.52%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	13.12
Ev/Ebit Ratio Avg TTM	14.69
Ev/Ebit Ratio Avg 3Y	14.69
Current VS TTM Avg	-10.67%
Current VS 3Y Avg	-10.67%
Current VS 5Y Avg	-29.29%

Ev/Ebitda Ratio	12.65
Ev/Ebitda Ratio Avg TTM	14.17
Ev/Ebitda Ratio Avg 3Y	14.17
Current VS TTM Avg	-10.70%
Current VS 3Y Avg	-10.70%
Current VS 5Y Avg	-29.44%

Ev/Assets Ratio	1.69
Ev/Assets Ratio Avg TTM	1.99
Ev/Assets Ratio Avg 3Y	1.94
Current VS TTM Avg	-15.08%
Current VS 3Y Avg	-12.71%
Current VS 5Y Avg	+7.01%

Ev/Sales Ratio	3.77
Ev/Sales Ratio Avg TTM	5.27
Ev/Sales Ratio Avg 3Y	10.23
Current VS TTM Avg	-28.40%
Current VS 3Y Avg	-63.16%
Current VS 5Y Avg	-61.80%

Current Ratio	5.17
Current Ratio Avg TTM	6.44
Current Ratio Avg 3Y	4.45
Current VS TTM Avg	-19.78%
Current VS 3Y Avg	+16.03%
Current VS 5Y Avg	-7.15%

Quick Ratio	5.12
Quick Ratio Avg TTM	6.39
Quick Ratio Avg 3Y	4.42
Current VS TTM Avg	-19.98%
Current VS 3Y Avg	+15.67%
Current VS 5Y Avg	-7.67%

ROIC	12.93%
ROIC Avg 3Y	(40.56%)
ROIC Avg 5Y	(29.26%)
Current VS 3Y Avg	+131.88%
Current VS 5Y Avg	+144.18%
Current VS 10Y Avg	+130.76%

ROA	19.25%
ROA Avg TTM	9.94%
ROA Avg 3Y	(5.18%)
Current VS TTM Avg	+93.61%
Current VS 3Y Avg	+471.89%
Current VS 5Y Avg	+457.98%

ROE	26.77%
ROE Avg TTM	33.94%
ROE Avg 3Y	(68.44%)
Current VS TTM Avg	-21.14%
Current VS 3Y Avg	+139.11%
Current VS 5Y Avg	+212.05%

Net Profit Margin	42.82%
Net Profit Margin Avg TTM	89.78%
Net Profit Margin Avg 3Y	(169.12%)
Current VS TTM Avg	-52.30%
Current VS 3Y Avg	+125.32%
Current VS 5Y Avg	+125.02%

Gross Profit Margin	84.52%
Gross Pft Margin Avg TTM	86.33%
Gross Pft Margin Avg 3Y	72.44%
Current VS TTM Avg	-2.10%
Current VS 3Y Avg	+16.68%
Current VS 5Y Avg	-10.07%

Tax Rate	31.59%
Tax Rate Avg 3Y	13.46%
Tax Rate Avg 5Y	10.77%
Current VS 3Y Avg	+134.72%
Current VS 5Y Avg	+193.40%
Current VS 10Y Avg	+368.94%